Natalie Sadowski
Publications by Year
Research Areas
Protein Degradation and Inhibitors, CAR-T cell therapy research, Ubiquitin and proteasome pathways, Neuroblastoma Research and Treatments, Chromatin Remodeling and Cancer
Most-Cited Works
- → Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2015)178 cited
- → The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models(2016)44 cited
- → MiR‐34a deficiency accelerates medulloblastoma formation in vivo(2014)42 cited
- → GSEA general cell biology gene sets from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → Data from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → Supplementary Figure 5. from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → MYCN targets OTX015_BRD4 and gene expression from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → All genes Hg19_BRD4_OTX from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)
- → Supplementary Figure 1. from Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2023)